Literature DB >> 22227279

CD38 and its role in oxytocin secretion and social behavior.

Haruhiro Higashida1, Shigeru Yokoyama, Mitsuru Kikuchi, Toshio Munesue.   

Abstract

Here, we review the functional roles of cyclic ADP-ribose and CD38, a transmembrane protein with ADP-ribosyl cyclase activity, in mouse social behavior via the regulation of oxytocin (OXT) release, an essential component of social cognition. Herein we describe data detailing the molecular mechanism of CD38-dependent OXT secretion in CD38 knockout mice. We also review studies that used OXT, OXT receptor (OXTR), or CD38 knockout mice. Additionally, we compare the behavioral impairments that occur in these knockout mice in relation to the OXT system and CD38. This review also examines autism spectrum disorder (ASD), which is characterized by social and communication impairments, in relation to defects in the OXT system. Two single nucleotide polymorphisms (SNPs) in the human CD38 gene are possible risk factors for ASD via inhibition of OXT function. Further analysis of CD38 in relation to the OXT system may provide a better understanding of the neuroendocrinological roles of OXT and CD38 in the hypothalamus and of the pathophysiology of ASD. This article is part of a Special Issue entitled Oxytocin, Vasopressin, and Social Behavior.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22227279     DOI: 10.1016/j.yhbeh.2011.12.011

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  41 in total

1.  Editorial comment: oxytocin, vasopressin and social behavior.

Authors:  Larry J Young; Loretta M Flanagan-Cato
Journal:  Horm Behav       Date:  2012-03       Impact factor: 3.587

2.  Towards Identifying Genetic Biomarkers for Gastrointestinal Dysfunction in Autism.

Authors:  A E Shindler; E L Hill-Yardin; S Petrovski; N Bishop; A E Franks
Journal:  J Autism Dev Disord       Date:  2020-01

Review 3.  The oxytocin system in drug discovery for autism: animal models and novel therapeutic strategies.

Authors:  Meera E Modi; Larry J Young
Journal:  Horm Behav       Date:  2011-12-20       Impact factor: 3.587

4.  Oxytocin-related single-nucleotide polymorphisms, family environment, and psychopathic traits.

Authors:  Edelyn Verona; Brett Murphy; Konrad Bresin
Journal:  Personal Disord       Date:  2018-06-21

5.  Genetic variation in CD38 and breastfeeding experience interact to impact infants' attention to social eye cues.

Authors:  Kathleen M Krol; Mikhail Monakhov; Poh San Lai; Richard P Ebstein; Tobias Grossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-14       Impact factor: 11.205

6.  Antiaggressive activity of central oxytocin in male rats.

Authors:  Federica Calcagnoli; Sietse F de Boer; Monika Althaus; Johan A den Boer; Jaap M Koolhaas
Journal:  Psychopharmacology (Berl)       Date:  2013-04-28       Impact factor: 4.530

7.  Parental oxytocin and early caregiving jointly shape children's oxytocin response and social reciprocity.

Authors:  Ruth Feldman; Ilanit Gordon; Moran Influs; Tamar Gutbir; Richard P Ebstein
Journal:  Neuropsychopharmacology       Date:  2013-01-16       Impact factor: 7.853

Review 8.  Oxytocin and vasopressin neural networks: Implications for social behavioral diversity and translational neuroscience.

Authors:  Zachary V Johnson; Larry J Young
Journal:  Neurosci Biobehav Rev       Date:  2017-05       Impact factor: 8.989

9.  Interaction of CD38 Variant and Chronic Interpersonal Stress Prospectively Predicts Social Anxiety and Depression Symptoms Over Six Years.

Authors:  Benjamin A Tabak; Suzanne Vrshek-Schallhorn; Richard E Zinbarg; Jason M Prenoveau; Susan Mineka; Eva E Redei; Emma K Adam; Michelle G Craske
Journal:  Clin Psychol Sci       Date:  2015-05-13

10.  Neonatal CSF oxytocin levels are associated with parent report of infant soothability and sociability.

Authors:  Catherine L Clark; Nicholas St John; Anca M Pasca; Shellie A Hyde; Kirsten Hornbeak; Marina Abramova; Heidi Feldman; Karen J Parker; Anna A Penn
Journal:  Psychoneuroendocrinology       Date:  2013-03-15       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.